Investor Presentation Q1FY23 slide image

Investor Presentation Q1FY23

Biocon Today: Strategically poised for a strong global play * Biocon Rs. 8,397 Cr | $1.1bn Revenue* ~15,000 Total Employees* P ~1,300 Patents* *FY22 凸 50+ CGMP approvals from International regulatory agencies 120+ Countries where our products are available Ranked 5 Among Top 10 Global Biotech Employers by Science magazine # BIOCON LIMITED6
View entire presentation